Pinealon (EDR Peptide): 20mg

Description

Pinealon (also known as the edr peptide, from its three amino acids glutamic acid, aspartic acid, arginine) is a synthetic tripeptide developed by professor vladimir khavinsky at the st. petersburg institute of bioregulation and gerontology, classified as a geroprotector — a compound designed to slow age-related biological decline. it is one of the smallest known neuroprotective peptides, with a molecular weight of 418.4 g/mol that allows it to cross the blood-brain barrier via the pept2 transporter system. pinealon's primary mechanism is epigenetic gene regulation: it directly influences the expression of genes involved in neurogenesis, memory formation, and circadian rhythm by entering cell nuclei and modulating transcription factor activity. it also increases irisin levels — a peptide linked to neuron proliferation and differentiation — and demonstrates antioxidant activity protecting neurons from oxidative and excitotoxic damage. research highlights include: 59.4% of patients recovering from traumatic brain injury showed measurable memory improvement when pinealon was added to standard rehabilitation; it is one of the active compounds in cortexin, a multi-peptide drug used clinically in several countries for tbi treatment. commonly stacked with epithalon for the complete khavinsky bioregulator protocol, and with pe-22-28 and selank for the calm and clarity blend. for research and educational purposes only.

Specifications

Dose Calculator